Position history for Verition Fund Management LLC's holdings in AVIDITY BIOSCIENCES INC
Verition Fund Management LLC holds 680,721 shares of RNA (AVIDITY BIOSCIENCES INC), worth $49.1M as of 2025-Q4. The position was increased (++1800.0% shares). RNA represents 0.2% of Verition Fund Management LLC's portfolio.
Current Value
$49.1M
Current Shares
680,721
Total Value Change
+$48.8M
Total Shares Change
+673,316
Other major holders of RNA: VANGUARD GROUP INC, FMR LLC, BlackRock, Inc., UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, BNP PARIBAS FINANCIAL MARKETS
Increased |
| 680,721 |
+1800.0% |
| $49.1M |
| 0.2% |
| $72.15 |
56 |
| 2025-Q3 | Increased | 35,827 | +14.2% | $1.6M | 0.0% | $42.63 | 29 |
| 2025-Q2 | Increased | 31,367 | +231.3% | $890,823 | 0.0% | $29.03 | 40 |
| 2025-Q1 | Decreased | 9,467 | -89.1% | $279,466 | 0.0% | $31.60 | 0 |
| 2024-Q4 | Increased | 87,102 | +326.6% | $2.5M | 0.0% | $29.18 | 42 |
| 2024-Q3 | Increased | 20,416 | +175.7% | $937,707 | 0.0% | $42.33 | 40 |
| 2024-Q2 | New | 7,405 | - | $302,494 | 0.0% | $40.85 | 32 |